Medical News Today: IBS: Telephone- and web-based CBT relieve symptoms

A trial finds that both web- and telephone-based cognitive behavioral therapy relieve symptoms of irritable bowel syndrome better than standard care alone.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Irritable Bowel Syndrome Source Type: news

Related Links:

AbstractPurpose of ReviewIrritable bowel syndrome (IBS) is a functional GI disorder that affects a large percentage of the population and presents a significant socio-economic burden on the society. In this article, we reviewed the evidence supporting various pharmacological treatment options for IBS.Recent FindingsRifaximin, eluxadoline, and alosetron have demonstrated that they reduce symptom severity improving quality of life in patients with IBS –diarrhea. Ramosetron is a promising agent in development. Peppermint oil has also demonstrated a positive impact on some symptoms of IBS. For IBS with constipation, trad...
Source: Current Gastroenterology Reports - Category: Gastroenterology Source Type: research
Cognitive behavioral therapy (CBT) delivered by phone or online leads to improvements in patient-reported outcomes in irritable bowel syndrome (IBS), according to a clinical trial from the U.K.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news
STOMACH bloating is often caused by eating certain food or drink or eating too much, but in some cases, it can be the sign of a condition known as irritable bowel syndrome . There are a number of unexpected things which could be triggering this gut condition.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Individuals with irritable bowel syndrome (IBS) may modify their diet, which may pose nutritional risk. Further, some dietary approaches, such as a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs), are restrictive and may contribute to nutritional inadequacy.
Source: Journal of the American Dietetic Association - Category: Nutrition Authors: Tags: Research Source Type: research
In this study, we identified the differentially abundant gut microbes between CRC and healthy samples using the Ratio Approach for Identifying Differential Abundance (RAIDA) algorithm (Sohn et al., 2015). The algorithm fitted the distribution of observed data with a modified zero-inflated lognormal (ZIL) model and estimated the statistical significance of abundance difference by the T-test. Furthermore, we used the GRAMMy algorithm (Xia et al., 2011) to estimate and analyze the relative abundance of gut microbes and diversity of the microbial communities. Finally, we constructed and analyzed a microbial association network...
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
Improvements in symptoms, life impact maintained at 12 months
Source: The Doctors Lounge - Psychiatry - Category: Psychiatry Tags: Gastroenterology, Psychiatry, Journal, Source Type: news
Condition:   Irritable Bowel Syndrome Characterized by Constipation Interventions:   Drug: Botanical Tincture;   Other: Placebo Sponsor:   Stamford Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
This review explores possible etiologies for nonceliac gluten sensitivity, as well as the complex relationship between NCGS and irritable bowel syndrome.Current Opinion in Gastroenterology
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Gastroenterology Journal Article Source Type: news
Little is known about the link between pathophysiologic factors and symptoms of irritable bowel syndrome (IBS), or whether these factors have cumulative effects on patient-reported outcomes (PROs). We investigated whether pathophysiologic alterations associated with IBS have cumulative or independent effects on PROs.
Source: Gastroenterology - Category: Gastroenterology Authors: Source Type: research
CONCLUSIONS: Considering a conservative estimate of 2,736,700 Italian adults affected by the syndrome, the minimum costs due to IBS in Italy - likely underestimated - range from 6 to 8 billion euro per year. Given the substantial economic burden for patients, healthcare systems and society, IBS should be included among the priorities of the public health agenda. PMID: 31002149 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Health | Irritable Bowel Syndrome